Vandetanib-d4 Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
A labelled Vandetanib; a once-daily oral inhibitor of vascular endothelial growth factor receptor-2 and epidermal growth factor receptor kinase activity. The activity of vandetanib plus docetaxel was
assessed in patients with previously treated non-small-cell lung cancer (NSCLC).
Vandetanib-d4 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte